Investment bank commits loans to fight antimicrobial resistance and pathogens with pandemic potential
The EU has created a €100 million fund for R&D into threats against human health, including antimicrobial resistance and pathogens with pandemic potential.
On 12 July, the European Investment Bank announced it had signed an agreement with the European Commission to establish the scheme, called Hera Invest, as a loan guarantee to support sector investment.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.